(Q41122353)

27 September 2017

Cholinergic activity and constraints on information processing (English)

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

13 October 2022

main subject

information processing

1 reference

E. Callaway

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599996

13 October 2022

R. Halliday

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599996

13 October 2022

H. Naylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599996

13 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1599996

13 October 2022

publication date

1 May 1992

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:030105119290002C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

https://api.elsevier.com/content/article/PII:030105119290002C?httpAccept=text/plain

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

13 October 2022

published in

Biological Psychology

1 reference

27 September 2017

33

1 reference

27 September 2017

1-22

1 reference

27 September 2017

1

1 reference

Effects of cigarette smoking on incidental memory

27 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The cholinergic hypothesis of geriatric memory dysfunction

13 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia

13 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Modelling dementia: effects of scopolamine on memory and attention

13 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Some psychopharmacological effects of atropine; preliminary investigation of broadened attention

13 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Effects of oral scopolamine on human stimulus evaluation

13 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Propranolol and response bias: an extension of findings reported by Corwin et al.

13 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cholinergic mechanisms in the control of behavior by the brain

13 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction?

13 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Physostigmine: effects on cognition and affect in normal subjects

13 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

13 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cholinergic mechanisms in depression

13 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Tobacco cigarette smoking and patellar reflex depression

13 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Memory and cognitive function in man: Does the cholinergic system have a specific role?

13 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Human memory and the cholinergic system. A relationship to aging?

13 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The Stroop effect: brain potentials localize the source of interference.

13 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis

13 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Scopolamine and the control of attention in humans.

13 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effect of emotion on cue utilization and the organization of behavior

13 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Evidence of more rapid stimulus evaluation following cigarette smoking

13 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.

13 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects of scopolamine and clonidine upon the performance and learning of a motor skill.

13 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

EP components, visual processing stages, and the effect of a barbiturate

13 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Problems and paradigms in ERP research

13 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Antagonism of diazepam by physostigmine.

13 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine

13 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Does scopolamine directly impair memory?

13 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects of stimulant drugs on information processing in elderly adults

13 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Beyond drug effects and dependent variables: the use of the Poisson-Erlang model to assess the effects of D-amphetamine on information processing

13 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

What's done can't always be undone: the effects of stimulant drugs and dopamine blockers on information processing

13 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

A cholinergic-adrenergic hypothesis of mania and depression

13 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release.

13 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Physostigmine in familial ataxias

13 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Atropine, scopolamine, and Ditran: Comparative pharmacology and antagonists in man

13 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

13 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart

13 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The water-jar Einstellung test as a measure of rigidity

13 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Central cholinergic systems and the P3 evoked potential.

13 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cholinergic and serotonergic effects on the P3 potential and recent memory

13 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

A metric for thought: a comparison of P300 latency and reaction time

13 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory

13 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Modern mental chronometry

13 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.

13 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Neurochemical dissociation of memory systems.

13 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Central nervous system effects of hyoscine in man

13 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Effects of two doses of methylphenidate on verbal information processing in hyperactive children.

13 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Memory deficits and anticholinergic levels in chronic schizophrenia.

13 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Scopolamine induced learning failures in man

13 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Clinical application of the P3 component of event-related potentials. I. Normal aging

13 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects of cigarette smoking on pain and anxiety

13 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Effects of parietal injury on covert orienting of attention.

13 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.

13 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Dissociative effects of scopolamine on working memory in healthy young volunteers.

13 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cognitive models and cholinergic drugs

13 October 2022

69

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

13 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The effect of aging on the stages of processing in a choice reaction time task

13 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping

13 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Choice reaction time: an analysis of the major theoretical positions.

13 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The discovery of processing stages: Extensions of Donders' method

13 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

13 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

A feature-integration theory of attention

13 October 2022

78

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

13 October 2022

79

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The facilitation of discrimination performance by physostigmine sulphate

13 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

The separate and combined effects of scopolamine and nicotine on human information processing

13 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.

13 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

Effects of nicotine on finger tapping rate in non-smokers

13 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/0301-0511(92)90002-C

13 October 2022

Identifiers

1 reference

27 September 2017

1 reference